Sponsor Review - TrialNet

Type 1 Diabetes TrialNet is the largest clinical trial network ever assembled to change the course of type 1 diabetes. The TrialNet family is made up of physicians, scientists and healthcare teams at the forefront of type 1 diabetes research. Funded by the National Institutes of Health, TrialNet offers risk screening for relatives of people with type 1 diabetes and innovative clinical studies to preserve insulin production. With the help of thousands of volunteers who are participating in their clinical studies, TrialNet is learning more and more about how T1D develops and testing new ways to maintain insulin production before and after diagnosis. TrialNet’s mission is to prevent T1D and stop disease progression by preserving insulin production before and after diagnosis.